Best Artificial Intelligence Stocks To Research – December 22nd

Hut 8, BigBear.ai, and Tempus AI are the three Artificial Intelligence stocks to watch today, according to MarketBeat’s stock screener tool. Artificial intelligence stocks are shares of publicly traded companies whose business models, products, or meaningful revenue streams are driven by AI technologies — including pure‑play AI developers (algorithms, models, tools, and chips) and established firms that materially benefit from AI adoption. For stock market investors, these stocks offer higher growth potential but often come with elevated valuation, execution, competitive and regulatory risks, so they require careful assessment of technological moat, data access, and realistic monetization pathways. These companies had the highest dollar trading volume of any Artificial Intelligence stocks within the last several days.

Hut 8 (HUT)

Hut 8 Corp., together with its subsidiaries, acquires, builds, manages, and operates data centers for digital assets mining, computing, and artificial intelligence in the United States. It operates in four segments: Digital Assets Mining, Managed Services, High Performance Computing Colocation and Cloud, and Other.

Read Our Latest Research Report on HUT

BigBear.ai (BBAI)

BigBear.ai Holdings, Inc. provides artificial intelligence-powered decision intelligence solutions. It offers national security, supply chain management, and digital identity and biometrics solutions. The company also provides data ingestion, data enrichment, data processing, artificial intelligence, machine learning, predictive analytics, and predictive visualization solutions and services.

Read Our Latest Research Report on BBAI

Tempus AI (TEM)

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Read Our Latest Research Report on TEM

See Also